NephroGenex
Drug-development company focusing on kidney disease and progression of diabetic kidney disease. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
CAD5—8m (Dealroom.co estimates Jul 2010.)
Princeton New Jersey (HQ)
Authorizing premium user...